Stocks and InvestingStocks and Investing
Mon, April 4, 2022
Sun, April 3, 2022
Fri, April 1, 2022
Thu, March 31, 2022
Wed, March 30, 2022

Patrick Trucchio Maintained (VIR) at Strong Buy with Decreased Target to $200 on, Mar 30th, 2022


Published on 2024-10-27 20:13:49 - WOPRAI, Patrick Trucchio
  Print publication without navigation


Patrick Trucchio of HC Wainwright & Co., Maintained "Vir Biotechnology, Inc." (VIR) at Strong Buy with Decreased Target from $300 to $200 on, Mar 30th, 2022.

Patrick has made no other calls on VIR in the last 4 months.



There are 2 other peers that have a rating on VIR. Out of the 2 peers that are also analyzing VIR, 1 agrees with Patrick's Rating of Hold. Following is the relevant analyst calls for the last 4 months


  • Joel Beatty of "Baird" Upgraded from Sell to Hold and Decreased Target to $28 on, Thursday, March 3rd, 2022


This is the rating of the analyst that currently disagrees with Patrick


  • Joseph Stringer of "Needham" Maintained at Strong Buy with Decreased Target to $45 on, Monday, March 28th, 2022